MONTREAL, March 10, 2026 (GLOBE NEWSWIRE) — Transcontinental Inc. (TSX: TCL.A TCL.B) (“TC Transcontinental” or the “Corporation”) is pleased to announce that, in connection with the closing of the sale of the Corporation’s Packaging Sector to ProAmpac Holdings Inc. and certain of its subsidiaries, as previously announced on March 6, 2026, the Board of Directors of the Corporation has authorized a special cash distribution of $20.00 (the “Distribution”) per Class A Subordinate Voting Share (the “Class A Shares”) and Class B Share (the “Class B Shares”), to be effected by: (i) a reduction of stated capital of approximately $7.00 per Class A Share, and (ii) a cash dividend for the balance of the Distribution. The Distribution will be payable on Friday, March 20, 2026 (the “Payment Date”),...

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, March 10, 2026 (GLOBE NEWSWIRE) — Trisura Group Ltd. (“Trisura” or the “Company”) (TSX:TSU), a leading specialty insurance company, announced today that it intends to issue $200 million principal amount of senior unsecured notes (the “Notes”). The Notes will be direct unsecured obligations of Trisura and will rank equally with all other unsecured and unsubordinated indebtedness of Trisura. The Notes will bear interest at a fixed annual rate of 4.015% until maturity on March 17, 2031. The Company intends to use the net proceeds from this offering of the Notes for general corporate purposes, and repayment of existing indebtedness. The Notes will be offered in Canada on a private placement basis in reliance upon exemptions from the prospectus...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FORDISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, March 10, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that it will release its financial and operational results for the quarter and year ended December 31, 2025, after financial markets close on March 24, 2026. The Company’s fourth fiscal quarter and year end 2025 financial and operational results will be available on SEDAR+, EDGAR, and on the Company’s website at https://www.quantumbiopharma.com/investors. Private Placement Offering The Company also announces that it intends to complete a non-brokered private placement offering (the “Offering”)...

Vancouver, BC, March 10, 2026 (GLOBE NEWSWIRE) — Deep Sea Minerals Corp. (CSE: SEAS) (OTCPK: DSEAF) (FSE: X45) (“Deep Sea” or the “Company”) a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to provide a corporate update to certain disclosure in its Canadian Securities Exchange Form 2A – Listing Statement dated January 19, 2026 (the “Listing Statement”), as a result of raising gross proceeds of $4,220,170 in its over-subscribed non-brokered private placement of common shares of the Company on February 6, 2026 (the “Over-Subscribed Offering”).Use of funds available Amount disclosed in the Listing Statement Updated amount as a result of the Over-Subscribed Offering(2)Accounting, general and administration fees $6,000 $250,000Audit...

Las Vegas, Nevada, March 10, 2026 (GLOBE NEWSWIRE) — SUMA Acquisition Corporation (NASDAQ: SUMAU) (the “Company”) today announced the pricing of its initial public offering of 15,000,000 units at a price of $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market under the symbol “SUMAU” and is expected to begin trading on March 11, 2026. Each unit issued in the offering consists of one Class A ordinary share of the Company and one right to receive one-fifth (1/5) of a Class A ordinary share upon the consummation of the Company’s initial business combination. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on NASDAQ under the symbols “SUMA” and “SUMAR,” respectively. The closing of the offering is anticipated to take...

BOLTON, Ontario, March 10, 2026 (GLOBE NEWSWIRE) — Titanium Transportation Group Inc. (“Titanium” or the “Company”) (TSX: TTNM, OTCQX: TTNMF), a provider of transportation and logistics services throughout North America, is pleased to announce that the holders (the “Shareholders”) of common shares in the capital of Titanium (the “Common Shares”) have approved the proposed plan of arrangement (the “Transaction”) involving TTNM Management Acquisition Limited (the “Purchaser”) at the special meeting of Shareholders (the “Meeting”) held earlier today. Pursuant to the Transaction, the Purchaser will acquire all of the issued and outstanding Common Shares, other than the Common Shares owned by the Rollover Shareholders (as defined in the Company’s management information circular dated February 4, 2026 (the “Circular”)), for cash consideration...